EdgarLookup

Armata Pharmaceuticals, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
PERRY MICHAEL S Award / Grant 10,000 10,000 May 17, 2007
PARKER H STEWART President & CEO Award / Grant 50,000 81,175 May 17, 2007
LEVY NELSON L Award / Grant 10,000 10,070 May 17, 2007
HAWLEY ROGER Award / Grant 10,000 10,000 May 17, 2007
DAVIE JOSEPH MD PHD Award / Grant 10,000 11,000 May 17, 2007
COOK JEREMY CURNOCK Chairman of the Board Award / Grant 15,000 15,000 May 17, 2007
CARTER BARRIE J PHD Executive Vice President Award / Grant 35,000 48,766 May 17, 2007
BOWMAN JACK L Award / Grant 10,000 10,500 May 17, 2007
BIOGEN IDEC INC Award / Grant 1,000,000 2,170,410 Nov 7, 2006
PARKER H STEWART President & CEO Purchase 8,440 $2.00 $16,880 31,175 Sep 5, 2006